InvestorsHub Logo
Followers 493
Posts 62722
Boards Moderated 0
Alias Born 08/28/2010

Re: Golden Cross post# 19

Friday, 09/27/2019 11:03:44 AM

Friday, September 27, 2019 11:03:44 AM

Post# of 95
Looks like it is being accumulated. Could see .10 short-term imho. Aside from the Merger News I also find this in the PR interesting as well:

Mount Tam is advancing its lead asset, TAM-01, toward an Investigational New Drug (IND) application with the FDA and has already completed non-GLP pre-clinical development. The lead indication for TAM-01 is expected to be the treatment of SLE. Mount Tam is also advancing follow-on compounds through the discovery process and is looking at a broad range of disease areas where novel mTOR inhibitors have been shown to have the potential to address unmet need.

https://www.newmediawire.com/news/mount-tam-and-banner-midstream-sign-merger-agreement-4831018


$MNTM